Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Conferences for Advances and Perspectives in Auditory Neurophysiology (APAN)
Neural Basis of Categories
Targeting to Lymphocytes Mediated by Synthetic Epitopes
Epidemiology and Clinical Course of HIV Nephropathy
Mechanisms of Community Facilitation and Metapopulation Dynamics of New England Cobble Beach Plants
Recently added grants:
Delivery of Powdered Vaccines for Improving Newborn Vaccination
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific EffectorProteins
HSV-2 specificity and phenotyping of tissue-based T cells in genital skin biopsies of HSV-2 reactivation
Phosphate homeostasis and uptake in Staphylococcus aureus
The pig: A novel large animal model of allergic eosinophilic esophagitis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025120-000
Application #
6688661
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant